Plaquenil maculopathy is a rare, but visually debilitating complication of using hydroxychloroquine medication. This course details utilizing special testing including Visual Fields and OCT for diagnosis. The American Academy of Ophthalmology management recommendations including treatment and follow-up will be discussed, including what constitutes high risk. New information about risk modification will help the optometrist manage patients on Plaquenil.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
Educate about side effects of Plaquenil maculopathy
Discuss testing for Plaquenil maculopathy
Discuss new applicable technology
Describe the ""flying saucer sign" to discover early toxic complications utilizing OCT
Define follow up timelines for evaluating Plaquenil maculopathy
Demonstrate understanding of new American Academy of Ophthalmology guidelines for proper dosage of Plaquenil
Disclosure(s):
Anthony DeWilde, OD: No financial relationships to disclose
